The Role Of Adjuvant Yoga Therapy In The Management Of Polycystic Ovary Syndrome: A Narrative Review
Keywords:
Yoga, Yoga therapy, PCOS, Polycystic Ovarian Syndrome, Stein Leventhal Syndrome, adjuvant therapyAbstract
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine–metabolic disorder affecting 8–13% of women of reproductive age, commonly associated with insulin resistance, hormonal imbalance, and psychological distress. Conventional therapies, including pharmacological and lifestyle interventions, often provide partial relief and face adherence challenges. Yoga has emerged as a promising adjuvant therapy offering a holistic, non-pharmacological approach to managing PCOS.
This narrative review synthesized studies published between 2010 and 2025 from PubMed, Scopus, Google Scholar, and ResearchGate using terms such as “Yoga,” “Polycystic Ovary Syndrome,” and “Adjuvant therapy.” Eligible randomized controlled trials, observational studies, and reviews were analysed.
Findings suggest that yoga improves insulin sensitivity, glucose metabolism, lipid profile, and body mass index (BMI). It also reduces serum testosterone, LH/FSH ratio, and anti-Müllerian hormone (AMH), enhancing ovulatory function and menstrual regularity. Psychologically, yoga alleviates stress, anxiety, and depression, thereby improving overall quality of life.
In conclusion, adjuvant yoga therapy provides a safe, cost-effective, and integrative strategy addressing the biological, psychological, and social dimensions of PCOS. Further multicentric trials and standardized protocols are essential to strengthen its inclusion in evidence-based clinical practice.
